Treatment of proliferative glomerulonephritis of systemic lupus erythematosus. Recent development and current recommendations;Traitement des glomérulonéphrites lupiques prolifératives. Évolution des idées et situation en 2008

Revue de Medecine Interne

Volumn 29, Issue 9, 2008, Pages 710-717

  Daugas, E ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Azathioprine; Cyclophosphamide; Mycophenolate mofetil; Prognosis; Proliferative glomerulonephritis; Renal failure; Systemic lupus erythematosus; Treatment

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID;

CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; DISEASE CLASSIFICATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; HISTOPATHOLOGY; HUMAN; KIDNEY FUNCTION; LONG TERM CARE; PREVALENCE; PROLIFERATIVE GLOMERULONEPHRITIS; PROPHYLAXIS; RECURRENT DISEASE; REMISSION; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; UNSPECIFIED SIDE EFFECT;

AZATHIOPRINE; CLINICAL PROTOCOLS; CYCLOPHOSPHAMIDE; GLOMERULONEPHRITIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYCOPHENOLIC ACID; PRACTICE GUIDELINES AS TOPIC;

EID: 49849093413     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.04.019     Document Type: Short Survey

References (22)

1. Cervera R., Abarca-Costalago M., Abramovicz D., Allegri F., Annunziata P., Aydintug A.O., et al. Lessons from the "Euro-Lupus Cohort". Ann Med Interne (Paris) 153 (2002) 530-536
2. Cameron J.S. Lupus nephritis. J Am Soc Nephrol 10 (1999) 413-424
3. Pollak V.E., Pirani C.L., Dujovne I., and Dillard M.G. The clinical course of lupus nephritis: relationship to the renal histologic findings. Perspect Nephrol Hypertens 1 Pt. 2 (1973) 1167-1181
4. Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82 (2003) 299-308
5. Fiehn C., Hajjar Y., Mueller K., Waldherr R., Ho A.D., and Andrassy K. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis 62 (2003) 435-439
6. Korbet S.M., Lewis E.J., Schwartz M.M., Reichlin M., Evans J., and Rohde R.D. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35 (2000) 904-914
7. Houssiau F.A., Vasconcelos C., D'Cruz D., Sebastiani G.D., de Ramon Garrido E., Danieli M.G., et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term follow-up of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum 50 (2004) 3934-3940
8. Illei G.G., Takada K., Parkin D., Austin H.A., Crane M., Yarboro C.H., et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term follow-up of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 46 (2002) 995-1002
9. Boumpas D.T., Austin III H.A., Vaughan E.M., Yarboro C.H., Klippel J.H., and Balow J.E. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119 (1993) 366-369
10. Boumpas D.T., Austin III H.A., Vaughn E.M., Klippel J.H., Steinberg A.D., Yarboro C.H., et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340 (1992) 741-745
11. Donadio Jr. J.V., Holley K.E., Ferguson R.H., and Ilstrup D.M. Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide. N Engl J Med 299 (1978) 1151-1155
12. Austin III H.A., Klippel J.H., Balow J.E., le Riche N.G., Steinberg A.D., Plotz P.H., et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314 (1986) 614-619
13. Steinberg A.D., and Steinberg S.C. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only. Arthritis Rheum 34 (1991) 945-950
14. Flanc R.S., Roberts M.A., Strippoli G.F., Chadban S.J., Kerr P.G., and Atkins R.C. Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Am J Kidney Dis 43 (2004) 197-208
15. Contreras G., Pardo V., Leclercq B., Lenz O., Tozman E., O'Nan P., et al. Sequential therapies for proliferative lupus nephritis. N Engl J Med 350 (2004) 971-980
16. Houssiau F.A., Vasconcelos C., D'Cruz D., Sebastiani G.D., Garrido Ed Ede R., Danieli M.G., et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46 (2002) 2121-2131
17. Chan T.M., Li F.K., Tang C.S., Wong R.W., Fang G.X., Ji Y.L., et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med 343 (2000) 1156-1162
18. Chan T.M., Tse K.C., Tang C.S., Mok M.Y., and Li F.K. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 16 (2005) 1076-1084
19. Ginzler E.M., Dooley M.A., Aranow C., Kim M.Y., Buyon J., Merrill J.T., et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 353 (2005) 2219-2228
20. Appel G.B., Dooley M.A., Ginzler E.M., Isenberg D., Jayne D., Solomons N., et al. MMF compared with CYC as induction therapy for lupus nephritis: ALMS results [abstract]. J Am Soc Nephrol 18 (2007) 47A SAFC057
21. Grootscholten C., Ligtenberg G., Hagen E.C., van den Wall Bake A.W., de Glas-Vos J.W., Bijl M., et al. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis: A randomized controlled trial. Kidney Int 70 (2006) 732-742
22. Daugas E., Nochy D., Huong D.L., Duhaut P., Beaufils H., Caudwell V., et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 13 (2002) 42-52